↓ Skip to main content

Dove Medical Press

Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment

Overview of attention for article published in Drug Design, Development and Therapy, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
2 X users
patent
2 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
166 Dimensions

Readers on

mendeley
234 Mendeley
citeulike
1 CiteULike
Title
Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment
Published in
Drug Design, Development and Therapy, May 2013
DOI 10.2147/dddt.s31564
Pubmed ID
Authors

Stuart Ibsen, Carolyn E Schutt, Sadik Esener

Abstract

The inherently toxic nature of chemotherapy drugs is essential for them to kill cancer cells but is also the source of the detrimental side effects experienced by patients. One strategy to reduce these side effects is to limit the healthy tissue exposure by encapsulating the drugs in a vehicle that demonstrates a very low leak rate in circulation while simultaneously having the potential for rapid release once inside the tumor. Designing a vehicle with these two opposing properties is the major challenge in the field of drug delivery. A triggering event is required to change the vehicle from its stable circulating state to its unstable release state. A unique mechanical actuation type trigger is possible by harnessing the size changes that occur when microbubbles interact with ultrasound. These mechanical actuations can burst liposomes and cell membranes alike allowing for rapid drug release and facilitating delivery into nearby cells. The tight focusing ability of the ultrasound to just a few cubic millimeters allows for precise control over the tissue location where the microbubbles destabilize the vehicles. This allows the ultrasound to highlight the tumor tissue and cause rapid drug release from any carrier present. Different vehicle designs have been demonstrated from carrying drug on just the surface of the microbubble itself to encapsulating the microbubble along with the drug within a liposome. In the future, nanoparticles may extend the circulation half-life of these ultrasound triggerable drug-delivery vehicles by acting as nucleation sites of ultrasound-induced mechanical actuation. In addition to the drug delivery capability, the microbubble size changes can also be used to create imaging contrast agents that could allow the internal chemical environment of a tumor to be studied to help improve the diagnosis and detection of cancer. The ability to attain truly tumor-specific release from circulating drug-delivery vehicles is an exciting future prospect to reduce chemotherapy side effects while increasing drug effectiveness.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 234 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 1%
France 1 <1%
Germany 1 <1%
Brunei Darussalam 1 <1%
Canada 1 <1%
Unknown 227 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 72 31%
Researcher 27 12%
Student > Master 26 11%
Student > Bachelor 21 9%
Student > Doctoral Student 13 6%
Other 32 14%
Unknown 43 18%
Readers by discipline Count As %
Engineering 55 24%
Agricultural and Biological Sciences 27 12%
Medicine and Dentistry 26 11%
Biochemistry, Genetics and Molecular Biology 13 6%
Chemistry 12 5%
Other 47 20%
Unknown 54 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2022.
All research outputs
#3,274,715
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#185
of 2,268 outputs
Outputs of similar age
#26,898
of 204,330 outputs
Outputs of similar age from Drug Design, Development and Therapy
#6
of 20 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.